e-learning
resources
Munich 2006
Monday 04.09.2006
Infections in immunocompromised patients
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Residential bathroom is a candidate for source of pulmonary
mycobacterium avium
complex infection
R. Maekura, Y. Nishiuchi, S. Kitada, A. Tamaru, M. Ito (Toyonaka, Osaka, Japan)
Source:
Annual Congress 2006 - Infections in immunocompromised patients
Session:
Infections in immunocompromised patients
Session type:
Poster Discussion
Number:
3209
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Maekura, Y. Nishiuchi, S. Kitada, A. Tamaru, M. Ito (Toyonaka, Osaka, Japan). Residential bathroom is a candidate for source of pulmonary
mycobacterium avium
complex infection. Eur Respir J 2006; 28: Suppl. 50, 3209
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Lung function in epidemiological studies from infancy to childhood with focus on urban environment
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Sentinel-site surveillance of Mycobacterium avium complex pulmonary disease
Source: Eur Respir J 2005; 26: 1092-1096
Year: 2005
Mycobacterium tuberculosis
(MTB) content in the air of in-patient facility for the management of pulmonary tuberculosis (TB)
Source: Eur Respir J 2001; 18: Suppl. 33, 340s
Year: 2001
No human transmission of Mycobacterium malmoense in a perfect storm setting
Source: Eur Respir J 2012; 40: 1576-1578
Year: 2012
Human-to-human transmission of Mycobacterium kansasii or victims of a shared source?
Source: Eur Respir J 2014; 44: 1085-1087
Year: 2014
Chronic pulmonary disease with Mycobacterium abscessus complex is a biofilm infection
Source: Eur Respir J 2015; 46: 1823-1826
Year: 2015
Management of
Mycobacterium avium
complex and
Mycobacterium abscessus
pulmonary disease: therapeutic advances and emerging treatments
Source: Eur Respir Rev, 31 (163) 210212; 10.1183/16000617.0212-2021
Year: 2022
Clinical relevance of differentiation between Mycobacterium avium and M. intracellulare in M. avium complex pulmonary disease in Croatia
Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities
Year: 2019
Risk factors for Mycobacterium tuberculosis infection among contacts of pulmonary tuberculosis patients
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology I
Year: 2012
Importance of identifying Mycobacterium bovis as a causative agent of human tuberculosis
Source: Eur Respir J 2010; 35: 692-694
Year: 2010
Clinical features of pulmonary
Mycobacterium avium intracellulare
complex disease with a solitary pulmonary nodule in Japan
Source: Eur Respir J 2005; 26: Suppl. 49, 687s
Year: 2005
Clinical and laboratory features of Mycobacterium avium complex infection in comparison with infection, caused by Mycobacterium tuberculosis, in HIV-infected patients
Source: International Congress 2019 – Tuberculosis and non-TB mycobacterial infection II
Year: 2019
The utility of a serodiagnosis for
mycobacterium avium
complex pulmonary disease diagnosed by the single available bronchial wash
Source: Eur Respir J 2004; 24: Suppl. 48, 206s
Year: 2004
Pulmonary diseases caused by non-tuberculous mycobacteria
Source: Eur Respir Mon 2012; 58: 25-37
Year: 2012
Serodiagnosis of Mycobacterium avium complex pulmonary disease in the USA
Source: Eur Respir J 2013; 42: 454-460
Year: 2013
Nontuberculous mycobacterial infections
Source: Eur Respir Mon 2011; 52: 115-129
Year: 2011
Antibody testing for Mycobacterium avium complex infection in cystic fibrosis patients
Source: International Congress 2018 – Cystic fibrosis: microbiological aspects and new treatments
Year: 2018
Discriminating active from latent tuberculosis by Mycobacterium tuberculosis (MTB)-peptide specific immunoresponses
Source: Annual Congress 2008 - Priorities for tuberculosis research in Europe: discussing the results of the Tuberculosis Network European Trials Group (TBNET)
Year: 2008
Isolation of
M. abscessus
from patients with
M. avium
complex (MAC) lung disease
Source: Annual Congress 2013 –Bacterial, fungal and mycobacterial infections
Year: 2013
Investigation of the inhibition of adherence of
Mycobacterium avium
complex (MAC) and
Mycobacterium tuberculosis
(MTB) to the respiratory mucosa
Source: Eur Respir J 2001; 18: Suppl. 33, 480s
Year: 2001
Mycobacterium avium
complex infection: phenotypes and outcomes
Source: Eur Respir J, 50 (3) 1701380; 10.1183/13993003.01380-2017
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept